Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation and multiple sclerosis

I S Neu, M Prosiegel, V Pfaffenrath

    Acta Neurologica Scandinavica
    |October 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Management of dysphagia in acute stroke : A prospective study for validation of current recommendations].

    Der Nervenarzt·2017
    Same author

    [FEES for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German Stroke Society].

    Der Nervenarzt·2014
    Same author

    Long-term functional outcome in patients with neurogenic dysphagia.

    NeuroRehabilitation·2014
    Same author

    [FEES in the stroke unit: recommendations for implementation in the clinical routine].

    Der Nervenarzt·2013
    Same author

    [Management of dysphagic patients with acute stroke].

    Der Nervenarzt·2012
    Same author

    Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial.

    Cephalalgia : an international journal of headache·2012

    Multiple sclerosis patients exhibit heightened blood platelet aggregation compared to healthy individuals. This finding suggests a potential role for platelet activity in the pathogenesis of multiple sclerosis.

    Area of Science:

    • Neurology
    • Hematology
    • Immunology

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system.
    • Platelets play a role in inflammation and thrombosis, which may be relevant in MS pathogenesis.

    Purpose of the Study:

    • To investigate potential alterations in blood platelet aggregation in patients with multiple sclerosis.
    • To compare platelet aggregation between MS patients and healthy controls.

    Main Methods:

    • Blood samples were collected from 30 patients with multiple sclerosis and 15 healthy individuals.
    • Platelet aggregation was measured both spontaneously and upon induction with adenosine diphosphate (ADP) and serotonin.

    Main Results:

    Related Experiment Videos

  • Patients with multiple sclerosis demonstrated significantly increased spontaneous platelet aggregation compared to controls.
  • Induced platelet aggregation (ADP and serotonin) was also elevated in the multiple sclerosis group.
  • These findings indicate heightened platelet reactivity in individuals with MS.

    • Conclusions:

    • Elevated platelet aggregation in multiple sclerosis patients suggests a potential contribution to disease pathology.
    • Further research is warranted to explore the pathogenetic significance of these platelet changes in MS.